Ledger.Open graph →
SEC Form D · filed August 6, 2018

Bolt Biotherapeutics, Inc

Offering
$13.4M
Sold
$13.4M
Exemption
Rule 506(b)
Industry
Other
Location
Redwood City, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Charles L. Adelmann, M.D · Bridgeport, CTDirectorDante Andrade · Dallas, TXDirectorWeaver H. Gaines · Newberry, FLExecAshish G. Khanna · Redwood City, CADirectorMir Joffrey · DALLAS, TXDirectorScott Graves · Los Angeles, CADirectorBryan H. Anderson · Phoenix, AZExecKirk H. Howell · Phoenix, AZDirectorMaximiliano H. Palacio · Phoenix, AZDirectorAshish G. Khanna · Redwood City, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗